Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Ravizzini

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nuclear Medicine Communications|March 20, 2021
Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancerAli Baiomy, Dawid Schellingerhout, Brian F Chapin, et al.
Diagnostics (Basel, Switzerland)|September 28, 2024
Predictive Value of Quantitative Parameters of <sup>18</sup>F-FDG PET/CT in Patients with LiposarcomaLucia Martiniova, Serageldin Kamel, Kalevi Kairemo, et al.
ESMO Open|April 10, 2019
Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCISTKalevi Kairemo, Eric M Rohren, Pete M Anderson, et al.
Cancers|September 28, 2023
Dosimetry of a Novel <sup>111</sup>Indium-Labeled Anti-P-Cadherin Monoclonal Antibody (FF-21101) in Non-Human PrimatesGregory Ravizzini, William Erwin, Louis De Palatis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2007
In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodiesTristan Barrett, Yoshinori Koyama, Yukihiro Hama, et al.
World Journal of Gastroenterology|January 24, 2022
Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenibAjalaya Teyateeti, Armeen Mahvash, James Long, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 24, 2023
MRI and PSMA PET/CT of Biochemical Recurrence of Prostate CancerMuhammad O Awiwi, Migena Gjoni, Raghunandan Vikram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2019
Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation TrialVivek Subbiah, Pete M Anderson, Kalevi Kairemo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Phase I Study of P-cadherin-targeted Radioimmunotherapy with <sup>90</sup>Y-FF-21101 Monoclonal Antibody in Solid TumorsVivek Subbiah, William Erwin, Osama Mawlawi, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nuclear Medicine Communications|March 20, 2021
Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancerAli Baiomy, Dawid Schellingerhout, Brian F Chapin, et al.
Diagnostics (Basel, Switzerland)|September 28, 2024
Predictive Value of Quantitative Parameters of <sup>18</sup>F-FDG PET/CT in Patients with LiposarcomaLucia Martiniova, Serageldin Kamel, Kalevi Kairemo, et al.
ESMO Open|April 10, 2019
Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCISTKalevi Kairemo, Eric M Rohren, Pete M Anderson, et al.
Cancers|September 28, 2023
Dosimetry of a Novel <sup>111</sup>Indium-Labeled Anti-P-Cadherin Monoclonal Antibody (FF-21101) in Non-Human PrimatesGregory Ravizzini, William Erwin, Louis De Palatis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2007
In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodiesTristan Barrett, Yoshinori Koyama, Yukihiro Hama, et al.
World Journal of Gastroenterology|January 24, 2022
Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenibAjalaya Teyateeti, Armeen Mahvash, James Long, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 24, 2023
MRI and PSMA PET/CT of Biochemical Recurrence of Prostate CancerMuhammad O Awiwi, Migena Gjoni, Raghunandan Vikram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2019
Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation TrialVivek Subbiah, Pete M Anderson, Kalevi Kairemo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Phase I Study of P-cadherin-targeted Radioimmunotherapy with <sup>90</sup>Y-FF-21101 Monoclonal Antibody in Solid TumorsVivek Subbiah, William Erwin, Osama Mawlawi, et al.
Pageof 3